Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma
Oncology·MeSH: Adenocarcinoma Of Esophagus
3 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Telisotuzumab Adizutecan | AbbVie Inc. (ABBV) |
Phase 2(1)
| Drug | Company |
|---|---|
| Leucovorin | AbbVie Inc. (ABBV) |
Phase 1(1)
| Drug | Company |
|---|---|
| Budigalimab | AbbVie Inc. (ABBV) |
Compare drugs
Frequently asked questions
How many drugs are in development for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma?
BioSniper tracks 3 drugs in development for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma across 1 company.
How many clinical trials target Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma?
There are 1 clinical trial targeting Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma tracked by BioSniper.
Deep-dive into Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis